Largest companies by total assets
total assets
| Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 201 | $915.53M | Healthcare | Biotechnology | United States | Nasdaq |
| 202 | $910.22M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 203 | $904.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 204 | $896.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 205 | $888.70M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 206 | $885.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 207 | $873.02M | Healthcare | Medical Devices | United States | Nasdaq |
| 208 | $852.49M | Healthcare | Biotechnology | United States | Nasdaq |
| 209 | $834.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 210 | $828.22M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 211 | $825.74M | Healthcare | Pharmaceuticals | United States | NYSE |
| 212 | $820.86M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 213 | $799.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 214 | $795.19M | Healthcare | Medical Devices | United States | Nasdaq |
| 215 | $791.03M | Healthcare | Medical Devices | United States | Nasdaq |
| 216 | $779.57M | Healthcare | Biotechnology | United States | Nasdaq |
| 217 | $772.32M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 218 | $761.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 219 | $752.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 220 | $751.85M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 221 | $744.50M | Healthcare | Pharmaceuticals | United States | NYSE |
| 222 | $743.34M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 223 | $735.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 224 | $729.70M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 225 | $724.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 226 | $721.79M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 227 | $715.84M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 228 | $704.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 229 | $703.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 230 | $701.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 231 | $691.16M | Healthcare | Biotechnology | United States | Nasdaq |
| 232 | $684.21M | Healthcare | Biotechnology | United States | Nasdaq |
| 233 | $676.64M | Healthcare | Medical Devices | United States | Nasdaq |
| 234 | $673.35M | Healthcare | Medical Devices | United States | Nasdaq |
| 235 | $672.44M | Healthcare | Biotechnology | United States | Nasdaq |
| 236 | $671.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 237 | $667.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 238 | $653.14M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 239 | $640.68M | Healthcare | Biotechnology | United States | Nasdaq |
| 240 | $640.55M | Healthcare | Medical Devices | United States | Nasdaq |
| 241 | $638.90M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 242 | $628.50M | Healthcare | Biotechnology | United States | Nasdaq |
| 243 | $611.14M | Healthcare | Biotechnology | United States | Nasdaq |
| 244 | $603.75M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 245 | $587.79M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 246 | $566.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 247 | $565.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 248 | $561.18M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 249 | $560.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 250 | $558.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 251 | $557.85M | Healthcare | Biotechnology | United States | Nasdaq |
| 252 | $557.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 253 | $557.39M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 254 | $550.09M | Healthcare | Biotechnology | United States | Nasdaq |
| 255 | $535.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 256 | $532.99M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 257 | $531.63M | Healthcare | Biotechnology | United States | Nasdaq |
| 258 | $527.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 259 | $523.54M | Healthcare | Biotechnology | United States | Nasdaq |
| 260 | $521.92M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 261 | $519.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 262 | $512.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 263 | $511.39M | Healthcare | Medical Devices | United States | Nasdaq |
| 264 | $492.63M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 265 | $492.62M | Healthcare | Biotechnology | United States | Nasdaq |
| 266 | $490.78M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 267 | $488.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 268 | $486.57M | Healthcare | Medical Devices | United States | Nasdaq |
| 269 | $481.49M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 270 | $479.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 271 | $479.35M | Healthcare | Medical Devices | United States | Nasdaq |
| 272 | $475.20M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 273 | $470.43M | Healthcare | Biotechnology | United States | Nasdaq |
| 274 | $467.78M | Healthcare | Biotechnology | United States | Nasdaq |
| 275 | $458.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 276 | $447.49M | Healthcare | Medical Devices | United States | Nasdaq |
| 277 | $446.93M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 278 | $443.68M | Healthcare | Medical Devices | United States | Nasdaq |
| 279 | $441.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 280 | $437.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 281 | $435.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 282 | $435.05M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 283 | $425.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 284 | $420.58M | Healthcare | Biotechnology | United States | Nasdaq |
| 285 | $412.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 286 | $411.90M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 287 | $406.66M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 288 | $406.45M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 289 | $404.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 290 | $398.46M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 291 | $396.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 292 | $396.45M | Healthcare | Biotechnology | United States | Nasdaq |
| 293 | $394.72M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 294 | $393.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 295 | $392.02M | Healthcare | Pharmaceuticals | United States | NYSE |
| 296 | $389.05M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 297 | $386.62M | Healthcare | Biotechnology | United States | Nasdaq |
| 298 | $383.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 299 | $376.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 300 | $368.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 750 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.